Roche has acquired mobile diabetes management platform mySugr to form a leading open platform for digital diabetes management. For Roche, the acquisition will allow the company to expand its position in the diabetes management market.As part of the acquisition, mySugr will remain as a separate legal entity with an open platform for all diabetes devices and services. Users will continue to have the ability to automatically upload blood glucose data from their preferred device into the mySugr
Read More
Patient Diabetes Apps | Chronic Disease Management | News, Analysis, Insights - HIT Consultant
Glooko Raises $35M to Expand Diabetes Data Platform Internationally
Glooko, a Mountain View, CA-based provider of diabetes data management has rasied $35 million in Series C funding led by Georgian Partners with participation from Insulet Corporation, Mayo Clinic, Canaan Partners, Social Capital, Medtronic and Samsung NEXT. The company plans to use the funding to expand its’ commercialization efforts in France, Germany, the U.K., Asia and the Middle East, and further development efforts in data analytics and artificial intelligence to provide personalized
Read More
Study: Glooko’s Diabetes Mobile App Improved Glucose & A1C Rates
Diabetes data management company Glooko announced that its mobile app was associated with a drop in average blood glucose, estimated A1C (eA1C) and hyperglycemia rates in people with diabetes, according to results of two retrospective studies. Furthermore, usage of the Glooko mobile app was also associated with an increase in blood glucose test rate. Increased blood glucose testing rates have been shown to directly correlate with improvements in glycemic control, as evidenced by this
Read More
WellDoc Founders Launch FDA-Cleared Mobile Insulin Titration App for Diabetes Management
The team that created the first FDA-cleared mobile app for diabetes management at WellDoc has launched a completely new digital health company, Amalgam Rx. The new company is focused on developing next-generation, evidence-based digital therapies that empower and engage patients with chronic diseases. Amalgam’s first product, iSage Rx is the first FDA 510(k)-cleared, prescription-only, mobile insulin titration app of all brands of basal insulin including Lantus, Levemir, Toujeo, Tresiba and
Read More
Samsung Health Integrates with WellDoc’s Consumer Diabetes Health App
Today, WellDoc announced it has entered a joint commercial partnership agreement with Samsung. The enhanced partnership with WellDoc gives Samsung an opportunity to serve global consumers who are ready to embrace the combined health innovations that both companies plan to offer. Samsung also becomes a distribution channel for WellDoc.The companies will integrate WellDoc’s newly-released consumer diabetes health app, BlueStar® C, with the recently launched Samsung Health, a mobile one-stop shop
Read More
Livongo Health Raises $52.5M to Expand Diabetes Management to International Markets
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has raised $52.5 million in growth funding co-led by existing investor General Catalyst and international investment company Kinnevik. Singapore-based EDBI, American Investment Holdings LLC, and Microsoft Ventures also joined the round including participation from previous investors. The company plans to utilize the funding to expand its diabetes management to international markets
Read More
Common Sensing, Welkin Health Partner to Develop Innovative Insulin Adherence Program
Insulin adherence remains a significant challenge with approximately 62 percent of patients discontinuing insulin in the first three months and 82 percent in the first year. To resolve this challenge, Common Sensing and Welkin Health have partnered to develop an innovative new program aimed at improving insulin adherence for people living with diabetes. A first-of-its-kind initiative, the program will combine insulin dosing data, wirelessly transmitted from Common Sensing’s Gocap™, real-time
Read More
Novo Nordisk, Glooko Team Up to Develop Digital Diabetes Solutions
Pharmaceutical company Novo Nordisk and Glooko, a remote patient monitoring platform for diabetes are teaming up to develop digital health solutions for diabetes. As part of the non-exclusive collaboration, both companies will work together to create co-branded digital health solutions that will deliver personalized, digital services to support people with diabetes in areas including treatment adherence and blood glucose management.For Novo Nordisk, the integration of these offerings within its
Read More
FDA Clears Wireless Integration of LifeScan’s OneTouch With WellDoc’s Diabetes Management Platform
The U.S. Food and Drug Administration (FDA) announced it has cleared the wireless integration of the OneTouch Verio Flex® blood glucose monitoring system with WellDoc Inc.'s clinically validated diabetes management platform, BlueStar®. The integration will create an integrated, connected experience for people with Type 2 diabetes and deliver value for healthcare providers. Integration DetailsUsing blood glucose data wirelessly and automatically transmitted from the OneTouch Verio Flex blood
Read More
Medtronic Integrates With Fitbit to Understand How Exercise Impacts Glucose Levels
Medtronic has announced a partnership with connected health provider Fitbit to integrate health and activity tracking to physicians and care teams for patients living with diabetes. With this integration, patients with Type 2 diabetes will be able to monitor their glucose levels and physical activity data via Medtronic's iPro(TM)2 myLog mobile app. Together, the partnership will provide meaningful insight on how exercise impacts glucose levels for more effective diabetes care
Read More
